Skip to main content
. 2021 Aug 20;3(1):vdab114. doi: 10.1093/noajnl/vdab114

Table 3.

Management of Secondary Treatment After Recurrence and Visual Function Before Secondary Treatment

Management of Secondary Treatment After Recurrence
Parameters Number of Patientsn = 18
Treatment
 Resection 2 (11%)
 FSRT 16 (89%)
FSRT
 Dose per fraction (Gy) 1.8
 Median total dose (Gy) 54.0
 Range total dose (Gy) 52.2–54.0
 Median GTV (range) in ccm 19.8 (10.9–134.3)
 Median PTV (range) in ccm 150.1 (18.8–454.4)
Visual Function Before Secondary Treatment
Baseline Stable/ Improved Worsened
Double vision 2 (11%) 1 (6%) 1 (6%)
Visual field restriction 8 (44%) 6 (33%) 2 (11%)
Visual impairment right eye 6 (33%) 0 (0%) 6 (33%)
Visual impairment left eye 5 (28%) 2 (11%) 3 (17%)

FSRT, fractionated stereotactic radiotherapy; GTV, gross tumor volume; PTV, planning target volume.